first glp 1 approval GLP-1 PILL: The FDA just approved the first ever GLP-1 pill for weight loss, according to a Novo Nordisk, the makers of Wegovy. Link in bio for the details Market Overview: GLP-1 Agonists and

SARS-coV-2: emerging role in the pathogenesis of various thyroid diseases

Bagsvaerd, Denmark: Novo Nordisk A/D

Limited clinical trial data to justify its use in COVID-19 Most of the clinical studies where NAC has been used (either alone or in combination with another drug) tend to focus on its use as a mucolytic in two population subgroups: paediatric populations at lower doses where its antioxidant effects are less evident (6) with studies dating mainly from the 1970s and 1980s of low quality evidence

Reduction in migraine and headache frequency and intensity with combined antioxidant prophylaxis (N-acetylcysteine, vitamin E, and vitamin C): a randomized sham-controlled pilot study